Tag: Cancer: Prostate
On-Site Genetic Testing for Prostate Cancer Increases Patient Compliance
Implementation of on-site guideline-based genetic testing for prostate cancer patients increased compliance from 33.3 to 98.7 percent
Trends in Genitourinary Cancers Examined in the United States
Among non-Hispanic Whites, highest incidence rates seen in Northeast for bladder cancer, Appalachia for kidney cancer
MRI-Targeted Biopsy Beneficial for Men With Elevated PSA
Fewer men in experimental group received diagnosis of clinically insignificant prostate cancer
Melanoma Diagnosis Linked to Increased Risk of Prostate Cancer
More than twofold increased risk of prostate cancer seen for men with first melanoma diagnosed 10 to 15 years before study recruitment
Treatment Without ADT Delays Initiation of Systemic Therapy in Prostate Cancer
Metastasis-directed therapy can delay initiation of systemic therapy in patients with solitary oligorecurrent metastatic lesion
Sequencing of ADT, RT Examined in Localized Prostate Cancer
Pooled analysis of 12 randomized trials suggests use of concurrent/adjuvant androgen deprivation therapy in combination with prostate-only radiotherapy may improve outcomes
Patients Favor Single-Port Robotic System for Uro-Oncology Surgery
Patients in the single-port versus multiport system group reported better cosmetic appearance, higher satisfaction with cosmetic appearance of surgical scar
Robotic Prostate Cancer Surgery Tied to Financial Harm in Younger Patients
Higher risk also seen among patients experiencing increased urinary symptoms
Neoadjuvant Novel Hormonal Agents Studied in High-Risk Prostate Cancer
Neoadjuvant therapy with an NHA associated with longer time to biochemical recurrence, prolonged metastasis-free survival
Coffee Intake Linked to Longer Prostate Cancer-Specific Survival
Longer prostate cancer-specific survival seen for specific subgroups, including those with the CYP1A2 AA genotype
